期刊文献+

VEGF在绝经后子宫内膜样腺癌中的表达及临床意义 被引量:1

The expression and significance of VEGF in postmenopausal endometrial adenocarcinoma
下载PDF
导出
摘要 目的:探讨血管内皮生长因子(VEGF)在绝经后子宫内膜样腺癌中的表达及临床意义。方法:选择我院30例绝经后子宫内膜样腺癌组织和30例绝经后正常子宫内膜组织,应用免疫组织化学、原位杂交组织化学分别从细胞蛋白水平和分子基因水平检测VEGF在绝经后子宫内膜样腺癌组织的表达。结果:VEGF在绝经后子宫内膜样腺癌组织的表达显著高于正常子宫内膜组织(P=0.000);VEGF与组织学分级相关:其表达按高、中、低分化顺序升高(P=0.007,P=0.001);但与病理分期无关(P=0.160)。结论:VEGF在绝经后子宫内膜样腺癌高表达,参与绝经后子宫内膜样腺癌的肿瘤血管形成,可能在该疾病的早期发生和发展中发挥重要作用。 Objective:The aim of the study was to illustrate the expression of vascular endothelial growth factor(VEGF) and relationship with pathologic parameter in postmenopausal endometrial adenocarcinoma.Methods:Thirty patients with postmenopausal endometrial adenocarcinoma and thirty patients with normal endometrial tissue were enrolled in our study from April 2006 to April 2009 in our department. VEGF mRNA and protein levels were detected by in situ hybridization histochemistry(ISHH) and immunohistochemistry(IHC).Results:VEGF expression were higher in postmenopausal endometrial adenocarcinoma than those corresponding normal tissue(P=0.000);VEGF expression was positively correlated with pathologic grade(P=0.007) ,while not with FIGO stage(P=0.160). There was correlation between the grade of tumour and VEGF overexpression(P=0.001).Conclusion:Enhanced expression of VEGF may play a important role in tumor development and early growth of postmenopausal endometrial adenocarcinoma.
出处 《现代妇产科进展》 CSCD 北大核心 2010年第7期531-534,共4页 Progress in Obstetrics and Gynecology
关键词 血管内皮生长因子 子宫内膜样腺癌 绝经 Vascular endothelial growth factor Endometrial adenocarcinoma Menopause
  • 相关文献

参考文献16

  • 1Folkman J. Tumor angiogenesis:a possible control point in tumor growth [ J ]. Ann Intern Med, 1995,82:96-100.
  • 2Folkman J. Seminars in medicine of the beth isarel hospital ,boston. Clinical applications of research on angiogenesis [J]. N Engl J Med,1995 ,333 :1757-1763.
  • 3Takeda T, Osuga K, Morishige K, et al. Change of plasma vascular endothelial growth factor level after uterine artery embolisation for leiomyomata [ J ]. BJOG, 2005,112 : 1437- 1439.
  • 4Fujimoto J, Ichigo S, Hirose R, et al. Expressions of vascular endothelial growth factor(VEGF) and its mRNA in uterine endometrial cancers [ J ]. Cancer Lett, 1998,134 : 15- 22.
  • 5Fujimoto J, Sakaguehi H, Hirose R, et al. Progestins suppress estrogen-induced expression of vascular endothelial growth factor (VEGF) subtypes in uterine endometrial cancer cell [ J ]. Cancer Lett, 1999,141 : 63-71.
  • 6Fujimoto J,Ichigo S, Sakaguchi H,et al. Expression of basic fibroblast growth factor and its mRNA in advanced uterine cervical cancers [ J ]. Cancer Lett, 1997,111:21-26.
  • 7Fujimoto J, Aoki I, Khatun S, et al. Clinical implications of expression of interleukin-8 related to myometrial invasion with angiogenesis in uterine endometrial cancers [ J ]. Ann Oncol,2002,13:430-434.
  • 8Leung WK,To KF, Go MY, et al. Cyclooxygenase-2 upregulates vascular endothelial growth factor expression and angiogenesis in human gastric carcinoma [ J ]. Int J Oncol, 2003,23 : 143-147.
  • 9Doldi N, Bassan M, Gulisano M, et al. vascular endothelial growth factor messenger ribonucleic acid expression in hun-man ovarian and endometrial cancer[ J]. Gynecol Endocrinol, 1996,10 : 375-382.
  • 10Fine BA, Valente PT, Feinstein GI, et al. VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma[ J ]. Gynecol Oncol,2000,76:33-39.

同被引文献22

  • 1杨剑锋,陈森林,刘志红,高妮娜,李程.p120^ctn在乳腺癌中的表达及意义[J].中国医师杂志,2007,9(7):893-895. 被引量:5
  • 2叶润椠 周永昌 电子版.国际乳腺癌治疗新动态[J/CD],中华乳腺病杂志[J].2009,.
  • 3Sinn BV, Darb Esfahani S, W irtz RM, et al. Vascular endothelial growth {actorC mRNA expression is a prognostic factor in epi- thelial ovarian cancer as detected by kinetic RT-PCR in form alin-fixed paraffin embedded tissue[J]. Virchows Arch, 2009,455 (6) :461-467.
  • 4Harlozinska A. Progress in molecular mechanisms o{ tumor me- tastasis and angiogenesis[J]. Antieancer Res, 2005,25 (5) : 3327- 3333.
  • 5Linderholm BK,Gruvberger-Saal S. Vascular endothelial growth factor is a strong predictor of early distant recurrences in a pro- spective study of premenopausal women with lymphnocle nega- tive breast cancer[J]. Breast,2008,17(5):484 491.
  • 6Bjorndahl MA,Cao R,Burton JB,et al. Vascular endothelial growth factor-a promotes peritumoral lymphagiogenesis and lymphatic metas tasis[J]. Cancer Res,2005,65(20) 9261-9268.
  • 7Shibata T, Kokubu A, Sekine S, et al. Cytoplasmic P120ctn regu lates the invasive phenotypes of E-cadherin-defieient breast canc- er[J. Am J Pathol,2004,164(6) :2269-2678.
  • 8Dillon DA,Daquila T,Reynolds Al3,et al. I he expression oi ilxucm protein in breast cancer is independent of alpha-and betweatenin and Kcadherin{-J]. Am J Pathol,1998,152(1) :74-82.
  • 9Tang WW, Stelter AA. French S, et al. Loss of cell-adhesion mol- ecule complexes in solid pseudopapillary tumor of pancreas]. Mod Pathoh2007,20(5) :509-513.
  • 10Brown MV,Burnett PE,Denning MF,et al. PDGF receptor acti- vation induces pl20-catenin phosphorylation at serine 879 via a PKC alpha-dependent pathwayJ]. Exp Cell Res, 2009,315 ( 1 ) : 39 49.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部